Stem cells in amniotic fluid as new tools to study human genetic diseases

Stem Cell Reviews

Volumn 3, Issue 4, 2007, Pages 256-264

  Siegel, Nicol ^a   Rosner, Margit ^a   Hanneder, Michaela ^a   Valli, Alessandro ^a   Hengstschläger, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Amniotic fluid; Oct 4; Pluripotency; Stem cell

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; TELOMERASE; UNCLASSIFIED DRUG;

AMNION FLUID; CELL DIFFERENTIATION; CYTOLOGY; EMBRYONIC STEM CELL; EPITHELIUM CELL; FEMALE; GENETIC DISORDER; GENETICS; HEALTH CARE FACILITY; HUMAN; METABOLISM; NERVE CELL; PREGNANCY; PRENATAL DIAGNOSIS; REVIEW; TISSUE ENGINEERING;

AMNIOTIC FLUID; BIOLOGICAL SPECIMEN BANKS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; EPITHELIAL CELLS; FEMALE; GENETIC DISEASES, INBORN; HUMANS; NEURONS; OCTAMER TRANSCRIPTION FACTOR-3; PREGNANCY; PRENATAL DIAGNOSIS; TELOMERASE; TISSUE ENGINEERING;

EID: 38949203869     PISSN: 15508943     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12015-007-9003-z     Document Type: Article

References (69)

1. Weissman, I. L. (2000). Stem cells: Units of development, units of regeneration, and units in evolution. Cell, 100, 157-168.
2. Rosenthal, N. (2003). Prometheus's vulture and the stem-cell promise. New England Journal of Medicine, 349, 267-274.
3. Schulman, A. (2005). The search for alternative sources of human pluripotent stem cells. Stem Cell Reviews, 1, 291-292.
4. Wood, A. (2005). Ethics and embryonic stem cell research. Stem Cell Reviews, 1, 317-324.
5. Kamm, F. M. (2005). Ethical issues in using and not using embryonic stem cells. Stem Cell Reviews, 1, 325-330.
6. Milunsky, A. (1979). Amniotic fluid cell culture. In A. Milunsky (Ed.) Genetic disorder and the fetus. New York: Plenum.
7. Hoehn, H., & Salk, D. (1982). Morphological and biochemical heterogeneity of amniotic fluid cells in culture. Methods in Cell Biology, 26, 11-34.
8. Gosden, C. M. (1983). Amniotic fluid cell types and culture. British Medical Bulletin, 39, 348-354.
9. Prusa, A., & Hengstschläger, M. (2002). Amniotic fluid cells and human stem cell research-A new connection. Medical Science Monitor, 8, 253-257.
10. Fauza, D. (2004). Amniotic fluid and placental stem cells. Best Practical Research in Clinical Obstetrics and Gynaecology, 18, 877-891.
11. Guillot, P. V., O'Donoghue, K., Kurata, H., & Fisk, N. M. (2006). Fetal stem cells: Betwixt and between. Seminars in Reproductive Medicine, 24, 340-347.
12. Delo, D. M., DeCoppi, P., Bartsch, G., & Atala, A. (2006). Amniotic fluid and placental stem cells. Methods in Enzymology, 419, 426-438.
13. Thakar, N., Priest, R. E., & Priest, J. H. (1982). Estrogen production by cultured amniotic fluid cells. Clinical Research, 30, 888A.
14. Whitsett, C. F., Priest, R. E., Priest, J. H., & Marion, J. (1983). HLA-typing of culture amniotic fluid cells. American Journal of Clinical Pathology, 79, 186.
15. Miki, T., & Strom, S. C. (2006). Amnion-derived pluripotent/ multipotent stem cells. Stem Cell Reviews, 2, 133-142.
16. Sakuragawa, N., Misawa, H., Ohsugi, K., Kakishita, K., Ishii, T., & Thangavel, R., et al. (1997). Evidence for active acetylcholine metabolism in human amniotic epithelial cells: Applicable to intracerebral allografting for neurologic disease. Neuroscience Letters, 232, 53-56.
17. Elwan, M. A., & Sakuragawa, N. (1997). Evidence for synthesis and release of catecholamines by human amniotic epithelial cells. Neuroreport, 8, 3435-3438.
18. Sakuragawa, N., Elwan, M. A., Fujii, T., & Kawashima, K. (1999). Possible dynamic neurotransmitter metabolism surrounding the fetus. Journal of Child Neurology, 11, 265-266.
19. Uchida, S., Inanaga, Y., Kobayashi, M., Hurukawa, S., Araie, M., & Sakuragawa, N. (2000). Neurptrophic function of conditioned medium from human amniotic epithelial cells. Journal of Neuroscience Research, 62, 585-590.
20. Marx, C. E., Vance, B. J., Jarskog, L. F., Chescheir, N. C., & Gilmore, J. H. (1999). Nerve growth factor, brain-derived neurothrophic factor, and neurotrophin-3 levels in human amniotic fluid. American Journal of Obstetrics and Gynecology, 181, 1225-1230.
21. Kakishita, K., Elwan, M., Nakao, N., Itakura, T., & Sakuragawa, N. (2000). Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: A potential source of donor for transplantation therapy. Experimental Neurology, 165, 27-34.
22. Kakishita, K., Nakao, N., Sakuragawa, N., & Itakura, T. (2003). Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. Brain Research, 980, 48-56.
23. Sankar, V., & Muthusamy, R. (2003). Role of human amniotic epithelial cell transplantation in spinal cord injury repair research. Neuroscience, 118, 11-17.
24. Wei, J. P., Zhang, T. S., Kawa, S., Aizawa, T., Ota, M., & Akaike, T., et al. (2003). Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplantation, 12, 545-552.
25. Takashima, S., Ise, H., Zhao, P., Akaike, T., & Nikaido, T. (2004). Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Structure and Function, 29, 73-84.
26. Miki, T., Lehmann, T., Cai, H., Stolz, D. B., & Strom, S. C. (2005). Stem cell characteristics of amniotic epithelial cells. Stem Cells, 23, 1549-1559.
27. Ilancheran, S., Michalska, A., Peh, G., Wallace, E. M., Pera, M., & Manuelpillai, U. (2007). Stem cells derived from human fetal membranes display multilineage differentiation potential. Biology of Reproduction, 77, 577-588.
28. Kaviani, A., Perry, T. E., Dzakovic, A., Jennings, R. W., Ziegler, M. M., & Fauza, D. O. (2001). The amniotic fluid as a source of cells for fetal tissue engineering. Journal of Pediatric Surgery, 36, 1662-1665.
29. Mitka, M. (2001). Amniotic cell show promise for fetal tissue engineering. The Journal of the American Medical Association, 286, 2083.
30. Fuchs, J. R., Kaviani, A., Oh, J. T., LaVan, D., Udagawa, T., & Jennings, R. W., et al. (2004). Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. Journal of Pediatric Surgery, 39, 834-838.
31. Kunisaki, S. M., Fuchs, J. R., Kaviani, A., Oh, J. T., LaVan, D. A., & Vacanti, J. P., et al. (2006). Hyperoncotic enhancement of fetal pulmonary growth after tracheal occlusion: An alveolar and capillary morphometric analysis. Journal of Pediatric Surgery, 41, 34-39.
32. Kunisaki, S. M., Freedman, D. A., & Fauza, D. O. (2006). Fetal tracheal reconstruction with cartilaginous grafts engineered from mesenchymal amniocytes. Journal of Pediatric Surgery, 41, 675-682.
33. Kunisaki, S. M., Armant, M., Kao, G. S., Stevenson, K., Kim, H., & Fauza, D. O. (2007). Tissue engineering from human mesenchymal amniocytes: A prelude to clinical trials. Journal of Pediatric Surgery, 42, 974-980.
34. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., & Mosca, J. D., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
35. Monk, M., & Holding, C. (2001). Human embryonic genes re-expressed in cancer cells. Oncogene, 20, 8085-8091.
36. Amit, M., Carpenter, M. K., Inokuma, M. S., Chiu, C. P., Waknitz, M. A., & Itskovitz-Eldor, J., et al. (2000). Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Developmental Biology, 227, 271-278.
37. Mosquera, A., Fernandez, J. L., Campos, A., Goyanes, V. J., Ramiro-Diaz, J., & Gosalvez, J. (1999). Simultaneous decrease of telomere length and telomerase activity with ageing of human amniotic fluid cells. Journal of Medical Genetics, 36, 494-496.
38. Prusa, A. R., Marton, E., Rosner, M., Freilinger, A., Bernaschek, G., & Hengstschläger, M. (2003). Stem cell marker expression in human trisomy 21 amniotic fluid cells and trophoblasts. Journal of Neural Transmission, 67, 235-242.
39. Pesce, M., & Schöler, H. R. (2001). Oct-4: Gatekeeper in the beginnings of mammalian development. Stem Cells, 19, 271-278.
40. Donavan, P. J. (2001). High Oct-ane fuel powers the stem cell. Nature Genetics, 29, 246-247.
41. Prusa, A. R., Marton, E., Rosner, M., Bernaschek, G., & Hengstschläger, M. (2003). Oct-4 expressing cells in human amniotic fluid: A new source for stem cell research? Human Reproduction, 18, 1489-1493.
42. Xu, C., Inokuma, M. S., Denham, J., Golds, K., Kundu, P., & Gold, J. D., et al. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nature Biotechnology, 19, 971-974.
43. Martin, F. H., Suggs, S. V., Langley, K. E., Lu, H. S., Ting, J., & Okino, K. H., et al. (1990). Primary structure and functional expression of rat and human stem cell factor DNAs. Cell, 63, 203-211.
44. Shamblott, M. J., Axelman, J., Littlefield, J. W., Blumenthal, P. D., Huggins, G. R., & Cui, Y., et al. (2001). Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proceedings of the National Academy of Sciences of the United States of America, 98, 113-118.
45. Tsai, M.-S., Lee, J.-L., Chang, Y.-J., & Hwang, S.-M. (2004). Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Human Reproduction, 19, 1450-1456.
46. Bossolasco, P., Montemurro, T., Cova, L., Zangrossi, S., Calzarossa, C., & Miatiotis, S., et al. (2006). Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Research, 16, 329-336.
47. Tsai, M.-S., Hwang, S.-M., Tsai, Y.-L., Lee, J.-L., & Chang, Y.-L. (2006). Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biology of Reproduction, 74, 545-551.
48. De Coppi, P., Bartsch, G., Siddiqui, M. M., Xu, T., Santos, T. X., & Perin, L., et al. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnology, 25, 100-106.
49. Kim, J., Lee, Y., Kim, H., Hwang, K. J., Kwon, H. C., & Kim, S. K., et al. (2007). Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Proliferation, 40, 75-90.
50. Karlmark, K. R., Freilinger, A., Marton, E., Rosner, M., Lubec, G., & Hengstschläger, M. (2005). Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells. International Journal of Molecular Medicine, 16, 987-992.
51. Buehr, M., Nichols, J., Stenhouse, F., Mountford, P., Greenhalgh, C. J., & Kantachuvesiri, S., et al. (2003). Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines. Biology of Reproduction, 68, 222-229.
52. Hosler, B. A., Larosa, G. J., Grippo, J. F., & Gudas, L. J. (1989). Expression of REX-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Molecular and Cellular Biology, 9, 5623-5629.
53. Ben-Shushan, E., Thompson, J. R., Gudas, L. J., & Bergman, Y. (1998). Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Molecular and Cellular Biology, 18, 1866-1878.
54. Du, Z.-W., Cong, H.-C., & Yao, Z. (2001). Identification of putative downstream genes of Oct-4 by suppression-subtractive hybridization. Biochemical and Biophysical Research Communications, 282, 701-706.
55. Eiges, R., Schuldiner, M., Drukker, M., Yanuka, O., Itskovitz-Eldor, J., & Benvenisty, N. (2001). Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Current Biology, 11, 514-518.
56. Siegel, N., Rosner, M., Hanneder, M., Freilinger, A., & Hengstschläger, M. (2007). Human amniotic fluid stem cells: A new perspective. Amino Acids, doi: 10.1007/s00726-007-0593-1.
57. Hengstschläger, M., Braun, K., Soucek, T., Miloloza, A., & Hengstschläger-Ottnad, E. (1999). Cyclin-dependent kinases at the G1-S transition of the mammalian cell cycle. Mutation Research-Reviews in Muation Research, 436, 1-9.
58. in 'tAnker, P. S., Scherjon, S. A., Kleijburg-van der Keur, C., Noort, W. A., Claas, F. H. J., Willemze, R., et al (2003). Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood, 102, 1548-1549.
59. Noort, W. A., Kruisselbrink, A. B., in 'tAnker, P. S., Kruger, M., van Bezooijen, R. L., & de Paus, R. A., et al. (2002). Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Experimental Hematology, 30, 870-878.
60. Prusa, A. R., Marton, E., Rosner, M., Bettelheim, D., Lubec, G., & Pollak, A., et al. (2004). Neurogenic cell in human amniotic fluid, American Journal of Obstetrics and Gynecology, 191, 309-314.
61. De Gemmis, P., Lapucci, C., Bertelli, M., Tognetto, A., Fanin, E., & Vettor, R., et al. (2006). A real-time PCR approach to evaluate adipogenic potential of amniotic fluid-derived human mesenchymal stem cells, Stem Cells and Development, 15, 719-728.
62. Rehni, A. K., Singh, N., Jaggi, A. S., & Singh, M. (2007). Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice, Behavioural Brain Research, 183, 95-100.
63. Tsai, M.-S., Hwang, S.-M., Chen, K.-D., Lee, Y.-S., Hsu, L.-W., Chang, Y.-J., et al (2007). Functional network analysis on the transcriptomes of mesechymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells, 25, 2511-2523.
64. DeCoppi, P., Callegari, A., Chiavegato, A., Gasparotto, L., Piccoli, M., Taiani, J., et al. (2007). Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells, Journal of Urology, 177, 369-376.
65. Kolambkar, Y. M., Peister, A., Soker, S., Atala, A., & Guldberg, R. E. (2007). Chondrogenic differentiation of amniotic fluid-derived stem cells. Journal of Molecular Histology, doi: 10.1007/s10735-007-9118-1.
66. Jones, D. G., Anderson, E. R., & Galvin, K. A. (2003). Spinal cord regeneration: Moving tentatively towards new perspectives, Neurological Rehabilitation, 18, 339-351.
67. Luque, J. M., & Gimenez y Ribotta, M. (2004). Neural stem cells and the quest for restorative neurology, Histology and Histopathology, 19, 271-280.
68. Ricard, J., & Liebl, D. J. (2004). Neurogenesis: Is the adult stem cell young or old?, International Union of Biochemistry and Molecular Biology Life, 56, 1-6.
69. Oh, J. E., Fountoulakis, M., Juranville, J. F., Rosner, M., Hengstschläger, M., & Lubec, G. (2004). Proteomic determination of metabolic enzymes of the amnion cells: Basis for a possible diagnostic tool?, Proteomics, 4, 1145-1158.